STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
JNJ JOHNSON & JOHNSON StockScouter® Report
6
StockScouter® Score
JOHNSON & JOHNSON, a large cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- One or more less experienced analysts has modestly increased quarterly earnings estimates for JNJ. Positive/Neutral
Concerns
- Short-term relative price momentum exhibits meaningful weakness. Negative
- The multi-period measure of relative price change and consistency is below average. Negative/Neutral
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that large cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
B
C
C
D